Business Context and Reporting Period
This Form 8-K Current Report was filed by XpresSpa Group, Inc. (trading symbol XSPA) on June 27, 2019. The filing details a completed amendment to existing debt instruments and outlines several advanced-stage discussions regarding new financing and strategic partnerships. The company is incorporated in Delaware and lists its common stock on The Nasdaq Stock Market.
Key Financial Metrics and Capital Structure Changes
The filing does not provide standard financial performance metrics such as revenue, net income, operating cash flow, or liquidity ratios for a specific reporting period. Instead, it focuses on capital structure modifications:
- Debt Conversion: Holders of Secured Convertible Notes due November 17, 2019, agreed to voluntarily convert all outstanding principal and interest at a reduced price of $2.48 per share.
- Dilution Impact: The conversion is expected to result in an additional 941,410 shares of Common Stock becoming outstanding.
- Proposed Financing (Calm): Discussions are underway for a $2,500,000 private placement of 5.00% unsecured convertible notes due 2022, alongside warrants equal to 75% of the principal amount.
- Proposed Financing (B3D): Discussions involve amending a credit agreement to extend maturity to May 31, 2021, potentially increasing principal in exchange for interest deferral, and converting up to $1.5 million of principal into common stock.
Material Changes and Strategic Developments
The primary material change is the execution of the Secured Convertible Notes Amendment, which alters the company's debt obligations and equity count effective June 28, 2019. Additionally, the company is pursuing significant strategic shifts:
- Calm Partnership: Advanced discussions for a collaboration agreement to market and sell Calm.com products in XpresSpa stores through July 31, 2021.
- Preferred Stock Amendment: Anticipated amendment to the Certificate of Designations for Series E Convertible Preferred Stock to increase authorized shares and potentially reduce the conversion price, subject to shareholder approval.
- Debt Restructuring: Potential extension of the B3D credit facility maturity and conversion of a portion of the debt into equity.
Outlook, Risks, and Contingencies
Management commentary indicates that the Calm Private Placement, Calm Collaboration Agreement, Series E COD Amendment, and B3D Transaction are all subject to ongoing negotiation. The filing explicitly states there can be no assurance these transactions will be completed on the described terms or at all. Key contingencies include:
- Shareholder Approval: Required for the issuance of Series E Preferred Stock as interest payment, anti-dilution adjustments, and the conversion of B3D notes into common stock.
- Automatic Warrant Conversion: If a Secured Convertible Note holder would own more than 4.99% of outstanding shares post-conversion, their notes will automatically convert into warrants with a $0.01 exercise price instead of shares.
- Forward-Looking Risks: The report includes standard disclaimers that actual results may differ materially from expectations due to risks outlined in the company's 2018 Form 10-K.
Investor Verification Checklist
- Verify the final closing of the Calm Private Placement and the specific exercise price for the Calm Warrants.
- Confirm whether shareholder approval is obtained for the Series E Preferred Stock conversion price reduction and B3D debt conversion.
- Monitor the actual issuance of the 941,410 shares resulting from the Secured Convertible Notes conversion.
- Review the final terms of the B3D Credit Agreement Amendment regarding the extended maturity date and interest deferral period.
- Assess the impact of the new equity issuances on existing shareholder dilution.